Recent Quotes (30 days)

You have no recent quotes
chg | %

Port Erin Biopharma Investments Ltd  

(Public, LON:PEBI)   Watch this stock  
Find more results forPEBI
6.75
-0.38 (-5.26%)
Real-time:   4:29pm BST
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 4.50 - 8.75
Open 7.12
Vol / Avg. 0.00/79,812.00
Mkt cap 2.23M*
P/E     -
Div/yield     -
EPS     -
Shares 33.00M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q2 (Jun '12) 2012
Net profit margin 167.03% -
Operating margin 166.76% -
EBITD margin - -
Return on average assets 39.23% -
Return on average equity 39.49% -
Carbon Disclosure Rating - -

Address

18 Athol Street
DOUGLAS, IM1 1JA
Isle of Man
+44-162-4620711 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance
Discussion Group - Google Finance

Description

Port Erin Biopharma Investments Ltd is an Isle of Man-based company that invests in the biotechnology and biopharmaceutical sector. The Company�s strategy is to create value for shareholders through investing in companies that have the potential to generate revenues through the development of biopharmaceutical drugs. Port Erin Biopharma Investments Ltd aims to establish a portfolio of 20 to 25 investments in biotechnology and biopharmaceutical companies, operating on the West Coast of the United States, where many biotechnology companies are based. The Company will invest in both quoted companies, which offer the benefits of liquidity and also in unquoted companies which offer the attraction of additional capital gains upon completion of an initial public offering. Port Erin Biopharma Investments Ltd will be a passive investor.

Officers and directors

Thomas J. Z. Winnifrith Chief Investment Officer
Age: 43
James Mellon Non-Executive Chairman of the Board
Age: 55
Denham Hervey Newall Eke Director
Age: 60
Alexander Anderson Stuart Whamond Non-Executive Director
Age: 52